跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 707 条关于
“AAV8-hSLC4A11”
全部
707
临床试验
130
药物
480
机构
0
资讯
97
去年
FDA Grants Rare Pediatric Disease and Orphan Drug Designations to Six Gene Therapies
2年前
Genethon's AAV Gene Therapy GNT0004 Shows Promise in Duchenne Muscular Dystrophy Trial
去年
U.S. Pharmacopeia Recognizes Mass Photometry as Key Method for AAV Gene Therapy Quality Standards
去年
AAVantgarde Bio Doses First Patient in Phase 1/2 Trial of AAVB-081 for Usher Syndrome Type 1B
4个月前
AAVantgarde Presents Interim LUCE-1 Trial Data for Usher Syndrome 1B Gene Therapy at ARVO 2026
去年
Imlifidase Shows Promise in Guillain-Barré Syndrome and Expands Gene Therapy Access
5个月前
AAV Gene Therapy Pipeline Surpasses 250 Candidates as FDA Approvals and Late-Stage Trials Accelerate in 2026
去年
AAVantgarde to Present Promising Gene Therapy Data for Usher 1B and Stargardt Disease at ARVO 2025
去年
AAVantgarde Bio Receives FDA Orphan Drug Designation for AAVB-081 in Usher Syndrome Type 1B
11个月前
Coave Therapeutics Advances Novel Gene Therapy for Retinal Vascular Diseases with Superior Suprachoroidal Capsid
第 1 页,共 10 页
上一页
下一页